缺血性脑卒中复发与相关因素分析

被引:72
作者
张文婷
陈茂刚
张敏
王启章
徐格林
刘新峰
机构
[1] 南京大学医学院临床学院南京军区南京总医院神经内科
关键词
脑缺血; 卒中; 复发; 高血压; 吸烟; 纤维蛋白原; 危险因素;
D O I
暂无
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
1002 ;
摘要
目的观察缺血性脑卒中患者2年复发率及复发的相关危险因素。方法采用前瞻性的队列研究方法,共纳入首发缺血性脑卒中患者860例,根据2年随访是否复发分为复发组(106例)和无复发组(754例)。并按照TOAST标准进行病因分型,大动脉粥样硬化型(LAA)261例,小动脉闭塞型(SAO)186例、心源性栓塞型(CES)191例、其他明确病因或不明原因型(UND)222例,随访2年,观察不同病因分型脑卒中复发率的差异,并进行多因素回归分析相关因素。结果复发组年龄、高血压、糖尿病、吸烟及纤维蛋白原水平较无复发组明显升高(P<0.05,P<0.01);抗血小板药物依从性较无复发组明显降低,差异有统计学意义(P<0.01)。复发脑卒中106例,其中LAA 29例,SAO 22例,CES 36例,UND 19例。多因素回归分析显示,年龄、高血压史、糖尿病史、纤维蛋白原、TOAST分型及抗血小板药物依从性与缺血性脑卒中复发相关。结论不同病因型脑卒中2年复发率存在差异;纤维蛋白原、TOAST病因分型及抗血小板药物依从性也是缺血性脑卒中复发的独立危险因素。
引用
收藏
页码:168 / 171
页数:4
相关论文
共 10 条
[2]  
Association of platelet responsiveness with clopidogrel metabolism: Role of compliance in the assessment of “resistance”[J] . Victor Serebruany,Ganesh Cherala,Craig Williams,Serge Surigin,Christopher Booze,Wiktor Kuliczkowski,Dan Atar.American Heart Journal . 2009 (6)
[3]   Factors associated with a high risk of recurrence in patients with transient ischemic attack or minor stroke [J].
Ois, Angel ;
Gomis, Meritxell ;
Rodriguez-Campello, Ana ;
Cuadrado-Godia, Elisa ;
Jimenez-Conde, Jordi ;
Pont-Sunyer, Claustre ;
Cuccurella, Gracia ;
Roquer, Jaume .
STROKE, 2008, 39 (06) :1717-1721
[4]   A survey on compliance with secondary stroke prevention guidelines and follow up for the inpatients with atherosclerotic cerebral infarction/transient ischemic attack [J].
Ma, Ruihua ;
Wang, Chunxue ;
Zhao, Xingquan ;
Xu, Mingjie ;
Lv, Ying ;
Wei, Ming ;
Cai, Yufen ;
Zhang, Zhuo ;
Wang, Li ;
Zhang, Weiwei ;
Huang, Yonghua ;
Li, Yao ;
Li, Hongtao ;
Wang, Yongjun .
NEUROLOGICAL RESEARCH, 2008, 30 (04) :383-388
[5]   Time frame and predictors of recovery from disability following recurrent ischemic stroke [J].
Hankey, G. J. ;
Spiesser, J. ;
Hakimi, Z. ;
Carita, P. ;
Gabriel, S. .
NEUROLOGY, 2007, 68 (03) :202-205
[6]   Predictors of recurrent stroke in African Americans [J].
Ruland, S. ;
Richardson, D. ;
Hung, E. ;
Brorson, J. R. ;
Cruz-Flores, S. ;
Felton, W. L., III ;
Ford-Lynch, G. ;
Helgason, C. ;
Hsu, C. ;
Kramer, J. ;
Mitsias, P. ;
Gorelick, P. B. .
NEUROLOGY, 2006, 67 (04) :567-571
[7]  
Prospective study of symptomatic atherothrombotic intracranial stenoses: The GESICA Study[J] . M Mazighi,R Tanasescu,X Ducrocq,E Vicaut,S Bracard,E Houdart,F Woimant.Neurology . 2006 (8)
[8]  
Recurrent stroke and cardiac risks after first ischemic stroke: The Northern Manhattan Study[J] . M S. Dhamoon,R R. Sciacca,T Rundek,R L. Sacco,M S.V. Elkind.Neurology . 2006 (5)
[9]  
Non–adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke[J] . E. L. L. M. Schryver,J. Gijn,L. J. Kappelle,P. J. Koudstaal,A. Algra.Journal of Neurology . 2005 (11)
[10]  
Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial[J] . Harold P. Adams,Birgitte H. Bendixen,L. Jaap Kappelle,José Biller,Betsy B. Love,David Lee Gordon,E. Eugene Marsh.Stroke . 1993 (1)